Health and Healthcare

Medtronic Adjusts Long-Term Goals (MDT)

Medtronic_logoMedical devices was supposed to be recession-proof, or at least was supposed to be recession-resistant.  But we have seen over and over how this notion has not been the case.  Medtronic Inc. (NYSE: MDT) today highlighted further evidence that medical technology has to adjust to a new, harsher environment.

The company was presenting data at the J.P. Morgan health careconference and it brought down some of its longer-term forecasts.  Itblamed a sluggish market for new implantable defibrillators, but theeconomy is the likely culprit here.

The company still expects earnings growth in the double-digits andit reaffirmed earnings targets for the fiscal April-2009 period.

Medtronic’s prior long-term sales growth over the next five years was 9% to 11%.  The company now sees sales growing 5% to 8% for near-term, but put its long-term earningsgrowth target at 10% or more.  Its prior growth target was roughly 11%to 14%.

This comes on the heels of its announcement that it plans to purchaseAblation Frontiers for an initial payment of $225 million pluspotential initial payments.  With a $36 billion market cap, thatacquisition will hardly be noticed any time soon.

Jon C. Ogg
January 12, 2009

Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE

Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.